Changes

{{draft|HPV vaccination}}

{{draft|HPV vaccination}}

'''Gardasil''' is a recently-available HPV [[vaccine]] intended to prevent infection with the human papillomavirus (HPV) in girls and women ages 9 to 26.<ref>[http://www.gardasil.com/who-should-receive-gardasil.html Who should recieve Gardasil?], Merck official website.</ref> <ref>The vaccine is designed to protect against types 6, 11, 16 and 18 of HPV.</ref>  

'''Gardasil''' is a recently-available [[vaccine]] intended to prevent infection with the human papillomavirus (HPV) in girls and women ages 9 to 26.<ref>[http://www.gardasil.com/who-should-receive-gardasil.html Who should recieve Gardasil?], Merck official website.</ref> <ref>The vaccine is designed to protect against types 6, 11, 16 and 18 of HPV.</ref>  

These strains of HPV are [[sexually transmitted diseases]] endemic among [[promiscuous]] people. These strains of HPV have been associated with 70% of cervical cancer cases and may also play a role in the development of other types of cancer <ref>[http://www.cancer.gov/cancertopics/factsheet/Risk/HPV]</ref>. In June 2006, the U.S. Food and Drug Administration approved the first HPV vaccine without reviewing any epidemiological studies and merely monitoring for a brief period elevated [[antibody]] levels in recipients of the vaccine.<ref> http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5602a1.htm</ref>

These strains of HPV are [[sexually transmitted diseases]] that are endemic among [[promiscuous]] people and have associated with 70% of cervical cancer cases.  They may also play a role in the development of other types of cancer <ref>[http://www.cancer.gov/cancertopics/factsheet/Risk/HPV]</ref>. In June 2006, the U.S. [[Food and Drug Administration]] approved the first HPV vaccine without reviewing any epidemiological studies and monitoring for only a brief period the elevated [[antibody]] levels in recipients of the vaccine.<ref> http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5602a1.htm</ref>

The HPV vaccine does not protect against other sexually transmitted diseases (e.g., chlamydia, herpes, hepatitis, trichomoniasis, gonorrhea, syphilis, [[HIV]], [[AIDS]], etc.).  The vaccine is not recommended for use in pregnant women or girls.[http://www.merck.com/product/usa/pi_circulars/g/gardasil/gardasil_pi.pdf]

The HPV vaccine does not protect against other sexually transmitted diseases (e.g., [[chlamydia]], herpes, [[hepatitis]], trichomoniasis, [[gonorrhea]], [[syphilis]], [[HIV]], [[AIDS]], etc.).  The vaccine is not recommended for use in pregnant women or girls.[http://www.merck.com/product/usa/pi_circulars/g/gardasil/gardasil_pi.pdf]

The long-term consequences of the HPV vaccine are not known and there have not been any long-term studies.  Children in the 9-year-old age group have been monitored for 18 months, and there have been no studies of possible longer-term risks of the vaccine.  Between July 2006 and January 2007, there were 82 reports of adverse events filed with the Vaccine Adverse Event Reporting System ([[VAERS]]) following the receipt of the vaccine.

The long-term consequences of the HPV vaccine are unknown as there have not been any long-term studies.  Children in the 9-year-old age group have been monitored for 18 months, and there have been no studies of possible longer-term risks of the vaccine.  Between July 2006 and January 2007, there were 82 reports of adverse events filed with the Vaccine Adverse Event Reporting System ([[VAERS]]) following the receipt of the vaccine.

A study published February 28, 2007 in the Journal of the American Medical Association (JAMA) <ref>JAMA 297(8):813-819, February 28, 2007</ref> disclosed that about 3% of women are infected in their lifetime by the particular types of HPV (Types 6, 11, 16, 18) targeted by the vaccine. ''Time'' magazine calls HPV "the most common sexually transmitted infection".<ref>[http://www.time.com/time/nation/article/0,8599,1206813,00.html  Defusing the War Over the "Promiscuity" Vaccine]</ref>

A study published February 28, 2007 in the Journal of the American Medical Association (JAMA) <ref>JAMA 297(8):813-819, February 28, 2007</ref> disclosed that about 3% of women are infected in their lifetime by the particular types of HPV (Types 6, 11, 16, 18) targeted by the vaccine. ''Time'' magazine calls HPV "the most common sexually transmitted infection".<ref>[http://www.time.com/time/nation/article/0,8599,1206813,00.html  Defusing the War Over the "Promiscuity" Vaccine]</ref>